光疗预防35周及以上新生儿严重高胆红素血症:技术报告
该技术报告总结光疗 principles 与应用,与美国儿科学会2022年临床实践指南修订版一致。综述美国光疗设备(蓝到蓝绿LED、荧光、卤素、光纤光源)及其适应症,指出设备疗效因光源、配置和辐照计非标准化差异大,最有效安全设备具备特定波长、辐照度和体表面积照射特征。
要点
- 最有效安全的光疗设备采用窄带蓝绿LED(约460-490 nm,最佳478 nm)以匹配胆红素吸收光谱。
- 足月婴儿辐照度至少30 µW/cm2/nm,并照射最大暴露体表面积(35%至80%)。
- 使用校准的辐照计准确测量,无溶血婴儿光疗后总血清胆红素在4至6小时内安全有效下降。
核心结论
- 有效光疗在无溶血婴儿中可安全有效地在开始后4至6小时内降低总血清或血浆胆红素浓度。
研究设计与样本
- 技术报告综述美国光疗设备相关文献,包括蓝到蓝绿LED、荧光、卤素或光纤光源及其当前市场适应症,与2022年美国儿科学会指南修订版一致。
主要发现
- 光疗设备疗效因光源和配置及辐照计非标准化使用而差异广泛。
关键数值与推荐
- 最有效安全设备特征:窄带蓝绿LED灯(约460-490 nm波长范围;最佳478 nm);足月婴儿辐照度至少30 µW/cm2/nm;照射婴儿最大暴露体表面积35%至80%。
临床怎么用
- 临床应选用具备窄带蓝绿LED、辐照度至少30 µW/cm2/nm且能照射最大暴露体表面积的光疗设备,并用校准辐照计测量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To summarize the principles and application of phototherapy consistent with the current 2022 American Academy of Pediatrics "Clinical Practice Guideline Revision for the Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation." METHODS: Relevant literature was reviewed regarding phototherapy devices in the United States, specifically those that incorporate blue to blue-green light-emitting diode, fluorescent, halogen, or fiberoptic light sources, and their currently marketed indications. RESULTS: The efficacy of phototherapy devices varies widely because of nonstandardized use of light sources and configurations and irradiance meters. In summary, the most effective and safest devices have the following characteristics: (1) incorporation of narrow band blue-to-green light-emitting diode lamps (∼460-490 nm wavelength range; 478 nm optimal) that would best overlap the bilirubin absorption spectrum; (2) emission of irradiance of at least 30 µW/cm2/nm (in term infants); and (3) illumination of the exposed maximal body surface area of an infant (35% to 80%). Furthermore, accurate irradiance measurements should be performed using the appropriate irradiance meter calibrated for the wavelength range delivered by the phototherapy device. CONCLUSIONS: With proper administration of effective phototherapy to an infant without concurrent hemolysis, total serum or plasma bilirubin concentrations will decrease within the first 4 to 6 hours of initiation safely and effectively.
引用
- Bhutani VK, Wong RJ, Turkewitz D, et al. Phototherapy to Prevent Severe Neonatal Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation: Technical Report. Pediatrics. 2024. PMID: 39183672. doi:10.1542/peds.2024-068026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。